Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Royalty Pharma plc (RPRX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Royalty Pharma plc (RPRX), most recent 12 months reported: revenue $2.54B, net income $815M. Latest balance sheet on file: liquid cash $836.99M, total debt $8.96B, net cash -$8.12B. From SEC filings. More on Royalty Pharma plc: Revenue · Profitability · Debt Others in Pharmaceutical Preparations: Perrigo Company plc · BIOMARIN PHARMACEUTICAL INC · United Therapeutics Corporation · AMNEAL PHARMACEUTICALS, INC. · SAREPTA THERAPEUTICS, INC. · Alkermes plc. · Phibro Animal Health Corporation · Indivior Pharmaceuticals, Inc.

Stock screener

Watchlist